Antidepressants and bleeding risk after face-lift surgery

Archives of Facial Plastic Surgery

Volumn 14, Issue 4, 2012, Pages 248-252

  Harirchian, Sanaz ^a   Zoumalan, Richard A ^b,c   Rosenberg, David B ^d  

^a University of Medicine and Dentistry of New Jersey   (United States)

^b Facial Plastic and Reconstructive Surgery (private practice)   (United States)

^c CEDARS SINAI MEDICAL CENTER   (United States)

^d EAR AND THROAT HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; SEROTONIN UPTAKE INHIBITOR;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BLEEDING; CASE CONTROL STUDY; CHEMICALLY INDUCED DISORDER; COMPARATIVE STUDY; FOLLOW UP; HEMATOMA; HOSPITALIZATION; HUMAN; INCIDENCE; MALE; METHODOLOGY; MIDDLE AGED; REFERENCE VALUE; RETROSPECTIVE STUDY; RHYTIDOPLASTY; RISK ASSESSMENT; SEX RATIO; TREATMENT OUTCOME;

ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; ANTIDEPRESSIVE AGENTS; CASE-CONTROL STUDIES; FOLLOW-UP STUDIES; HEMATOMA; HEMORRHAGE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; REFERENCE VALUES; RETROSPECTIVE STUDIES; RHYTIDOPLASTY; RISK ASSESSMENT; SEROTONIN UPTAKE INHIBITORS; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION; TREATMENT OUTCOME;

EID: 84864238210     PISSN: 15212491     EISSN: 15383660     Source Type: Journal    
DOI: 10.1001/archfacial.2012.2     Document Type: Article

References (43)

1. Zoumalan R, Rizk SS. Hematoma rates in drainless deep-plane face-lift surgery with and without the use of fibrin glue. Arch Facial Plast Surg. 2008;10(2):103-107.
2. Kamer FM, Song AU. Hematoma formation in deep plane rhytidectomy. Arch Facial Plast Surg. 2000;2(4):240-242.
3. Baker DC, Stefani WA, Chiu ES. Reducing the incidence of hematoma requiring surgical evacuation following male rhytidectomy: a 30-year review of 985 cases. Plast Reconstr Surg. 2005;116(7):1973-1985.
4. Grover R, Jones BM, Waterhouse N. The prevention of haematoma following rhytidectomy: a review of 1078 consecutive facelifts. Br J Plast Surg. 2001;54(6): 481-486. (Pubitemid 32851232)
5. Rees TD, Lee YC, Coburn RJ. Expanding hematoma after rhytidectomy: a retrospective study. Plast Reconstr Surg. 1973;51(2):149-153.
6. Barker DE. Prevention of bleeding following a rhytidectomy. Plast Reconstr Surg. 1974;54(6):651-653.
7. Straith RE, Raju DR, Hipps CJ. The study of hematomas in 500 consecutive face lifts. Plast Reconstr Surg. 1977;59(5):694-698. (Pubitemid 8083852)
8. Lawson W, Naidu RK. The male facelift: an analysis of 115 cases. Arch Otolaryngol Head Neck Surg. 1993;119(5):535-539. (Pubitemid 23143055)
9. Rees TD, Barone CM, Valauri FA, Ginsberg GD, Nolan WB III. Hematomas requiring surgical evacuation following face lift surgery. Plast Reconstr Surg. 1994; 93(6):1185-1190. (Pubitemid 24273747)
10. Perkins SW, Williams JD, Macdonald K, Robinson EB. Prevention of seromas and hematomas after face-lift surgery with the use of postoperative vacuum drains. Arch Otolaryngol Head Neck Surg. 1997;123(7):743-745. (Pubitemid 27299224)
11. Jones BM, Grover R, Hamilton S. The efficacy of surgical drainage in cervicofacial rhytidectomy: a prospective, randomized, controlled trial. Plast Reconstr Surg. 2007;120(1):263-270. (Pubitemid 46956062)
12. Por YC, Shi L, Samuel M, Song C, Yeow VK. Use of tissue sealants in face-lifts: a meta-analysis. Aesthetic Plast Surg. 2009;33(3):336-339.
13. McCloskey DJ, Postolache TT, Vittone BJ, et al. Selective serotonin reuptake inhibitors: measurement of effect on platelet function. Transl Res. 2008;151(3): 168-172. (Pubitemid 351227436)
14. De Clerck F. The role of serotonin in thrombogenesis. Clin Physiol Biochem. 1990; 8(suppl 3):40-49.
15. Meijer WE, Heerdink ER, Nolen WA, Herings RMC, Leufkens HGM, Egberts ACG. Association of risk of abnormal bleeding with degree of serotonin reuptake inhibition by antidepressants. Arch Intern Med. 2004;164(21):2367-2370. (Pubitemid 39532249)
16. Hergovich N, Aigner M, Eichler HG, Entlicher J, Drucker C, Jilma B. Paroxetine decreases platelet serotonin storage and platelet function in human beings. Clin Pharmacol Ther. 2000;68(4):435-442.
17. Dall M, Schaffalitzky de Muckadell OB, Lassen AT, Hansen JM, Hallas J. An association between selective serotonin reuptake inhibitor use and serious upper gastrointestinal bleeding. Clin Gastroenterol Hepatol. 2009;7(12):1314-1321.
18. Dalton SO, Johansen C, Mellemkjaer L, Nørgård B, Sørensen HT, Olsen JH. Use of selective serotonin reuptake inhibitors and risk of upper gastrointestinal tract bleeding: a population-based cohort study. Arch Intern Med. 2003;163 (1):59-64. (Pubitemid 36091601)
19. Turner MS, May DB, Arthur RR, Xiong GL. Clinical impact of selective serotonin reuptake inhibitors therapy with bleeding risks. J Intern Med. 2007;261(3): 205-213.
20. Serebruany VL. Selective serotonin reuptake inhibitors and increased bleeding risk: are we missing something? Am J Med. 2006;119(2):113-116. (Pubitemid 43151473)
21. Yuan Y, Tsoi K, Hunt RH. Selective serotonin reuptake inhibitors and risk of upper GI bleeding: confusion or confounding? Am J Med. 2006;119(9):719-727. (Pubitemid 44291626)
22. Targownik LE, Bolton JM, Metge CJ, Leung S, Sareen J. Selective serotonin reuptake inhibitors are associated with a modest increase in the risk of upper gastrointestinal bleeding. Am J Gastroenterol. 2009;104(6):1475-1482.
23. Kharofa J, Sekar P, Haverbusch M, et al. Selective serotonin reuptake inhibitors and risk of hemorrhagic stroke. Stroke. 2007;38(11):3049-3051. (Pubitemid 350035702)
24. Douglas I, Smeeth L, Irvine D. The use of antidepressants and the risk of haemorrhagic stroke: a nested case control study. Br J Clin Pharmacol. 2011;71(1): 116-120.
25. Salkeld E, Ferris LE, Juurlink DN. The risk of postpartum hemorrhage with selective serotonin reuptake inhibitors and other antidepressants. J Clin Psychopharmacol. 2008;28(2):230-234. (Pubitemid 351417131)
26. Napeñas JJ, Hong CHL, Kempter E, Brennan MT, Furney SL, Lockhart PB. Selective serotonin reuptake inhibitors and oral bleeding complications after invasive dental treatment. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2011; 112(4):463-467.
27. Kim DH, Daskalakis C, Whellan DJ, et al. Safety of selective serotonin reuptake inhibitor in adults undergoing coronary artery bypass grafting. Am J Cardiol. 2009; 103(10):1391-1395.
28. Xiong GL, Jiang W, Clare RM, et al. Safety of selective serotonin reuptake inhibitor use prior to coronary artery bypass grafting. Clin Cardiol. 2010;33(6):E94-98.
29. Andreasen JJ, Riis A, Hjortdal VE, Jørgensen J, Sørensen HT, Johnsen SP. Effect of selective serotonin reuptake inhibitors on requirement for allogeneic red blood cell transfusion following coronary artery bypass surgery. Am J Cardiovasc Drugs. 2006;6(4):243-250. (Pubitemid 44285133)
30. Gärtner R, Cronin-Fenton D, Hundborg H, et al. Use of selective serotonin reuptake inhibitors and risk of re-operation due to post-surgical bleeding in breast cancer patients: a Danish population-based cohort study. BMC Surg. 2010;10:3.
31. van Haelst IMM, Egberts TCG, Doodeman HJ, et al. Use of serotonergic antidepressants and bleeding risk in orthopedic patients. Anesthesiology. 2010;112 (3):631-636.
32. Shim RS, Baltrus P, Ye J, Rust G. Prevalence, treatment, and control of depressive symptoms in the United States: results from the National Health and Nutrition Examination Survey (NHANES), 2005-2008. J Am Board Fam Med. 2011;24 (1):33-38.
33. Zajecka J, Tracy KA, Mitchell S. Discontinuation symptoms after treatment with serotonin reuptake inhibitors: a literature review. J Clin Psychiatry. 1997;58 (7):291-297. (Pubitemid 27362484)
34. Michelson D, Fava M, Amsterdam J, et al. Interruption of selective serotonin reuptake inhibitor treatment: double-blind, placebo-controlled trial. Br J Psychiatry. 2000;176:363-368.
35. Fava M. Prospective studies of adverse events related to antidepressant discontinuation. J Clin Psychiatry. 2006;67(suppl 4):14-21. (Pubitemid 43764533)
36. Warner CH, Bobo W, Warner C, Reid S, Rachal J. Antidepressant discontinuation syndrome. Am Fam Physician. 2006;74(3):449-456. (Pubitemid 44285164)
37. Skop BP, Brown TM. Potential vascular and bleeding complications of treatment with selective serotonin reuptake inhibitors. Psychosomatics. 1996;37 (1):12-16. (Pubitemid 26021814)
38. Li N, Wallén NH, Ladjevardi M, Hjemdahl P. Effects of serotonin on platelet activation in whole blood. Blood Coagul Fibrinolysis. 1997;8(8):517-523. (Pubitemid 28023394)
39. Hougardy DMC, Egberts TCG, van der Graaf F, Brenninkmeijer VJ, Derijks LJ. Serotonin transporter polymorphism and bleeding time during SSRI therapy. Br J Clin Pharmacol. 2008;65(5):761-766. (Pubitemid 351535089)
40. Ahrens T, Frankhauser P, Lederbogen F, Deuschle M. Effect of single-dose sertraline on the hypothalamus-pituitary-adrenal system, autonomic nervous system, and platelet function. J Clin Psychopharmacol. 2007;27(6):602-606. (Pubitemid 351339447)
41. Carvajal A, Ortega S, Del Olmo L, et al. Selective serotonin reuptake inhibitors and gastrointestinal bleeding: a case-control study. PLoS One. 2011;6(5):e19819.
42. Bak S, Tsiropoulos I, Kjaersgaard JO, et al. Selective serotonin reuptake inhibitors and the risk of stroke: a population-based case-control study. Stroke. 2002; 33(6):1465-1473. (Pubitemid 34619941)
43. Valuck RJ, Orton HD, Libby AM. Antidepressant discontinuation and risk of suicide attempt: a retrospective, nested case-control study. J Clin Psychiatry. 2009; 70(8):1069-1077.